News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TransForm Pharmaceuticals, Inc. Receives Milestone Payment From AstraZeneca (AZN)



10/19/2005 5:12:20 PM

TransForm Pharmaceuticals, Inc. (TransForm) announced today that it received an initial milestone payment in connection with having successfully concluded a series of crystallization studies under its relationship with AstraZeneca.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES